Roberta Guzman

951 total citations
11 papers, 684 citations indexed

About

Roberta Guzman is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roberta Guzman has authored 11 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roberta Guzman's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Roberta Guzman is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Roberta Guzman collaborates with scholars based in United States, Germany and Italy. Roberta Guzman's co-authors include Michael F. Press, Angela Santiago, Ivonne Villalobos, Yanling Ma, Dennis J. Slamon, Guido Sauter, Leslie Bernstein, A. Riva, Jianyuan Zhou and Martina Mirlacher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Roberta Guzman

11 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Guzman United States 8 539 289 248 235 107 11 684
Kathleen Tenner United States 13 658 1.2× 336 1.2× 244 1.0× 185 0.8× 113 1.1× 30 792
Angela Santiago United States 7 516 1.0× 289 1.0× 216 0.9× 230 1.0× 115 1.1× 9 665
M. Pegram United States 6 453 0.8× 182 0.6× 199 0.8× 177 0.8× 82 0.8× 14 571
Ivonne Villalobos United States 10 681 1.3× 398 1.4× 309 1.2× 296 1.3× 148 1.4× 13 863
M. Gabriela Kuba United States 10 529 1.0× 101 0.3× 211 0.9× 399 1.7× 110 1.0× 17 780
Jill J.J. Geenen Netherlands 6 567 1.1× 257 0.9× 144 0.6× 209 0.9× 167 1.6× 10 706
Edward Clark United States 6 468 0.9× 223 0.8× 279 1.1× 330 1.4× 85 0.8× 6 764
In Ah Park South Korea 19 765 1.4× 95 0.3× 215 0.9× 252 1.1× 137 1.3× 28 1.1k
Merdol Ibrahim United Kingdom 15 469 0.9× 262 0.9× 275 1.1× 254 1.1× 146 1.4× 19 735
Hyesil Seol South Korea 15 480 0.9× 207 0.7× 307 1.2× 264 1.1× 244 2.3× 34 853

Countries citing papers authored by Roberta Guzman

Since Specialization
Citations

This map shows the geographic impact of Roberta Guzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Guzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Guzman more than expected).

Fields of papers citing papers by Roberta Guzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Guzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Guzman. The network helps show where Roberta Guzman may publish in the future.

Co-authorship network of co-authors of Roberta Guzman

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Guzman. A scholar is included among the top collaborators of Roberta Guzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Guzman. Roberta Guzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cohen, Evan N., Gitanjali Jayachandran, Richard G. Moore, et al.. (2023). Abstract P5-06-01: A Multi-center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System in support of FDA clearance. Cancer Research. 83(5_Supplement). P5–6. 1 indexed citations
2.
Cohen, Evan N., Gitanjali Jayachandran, Richard G. Moore, et al.. (2022). A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System. Cancers. 14(21). 5238–5238. 33 indexed citations
3.
Press, Michael F., Bin Xie, Yu Zhou, et al.. (2019). Role for polo-like kinase 4 in mediation of cytokinesis. Proceedings of the National Academy of Sciences. 116(23). 11309–11318. 33 indexed citations
4.
Press, Michael F., José A. Seoane, Christina Curtis, et al.. (2018). Assessment ofERBB2/HER2Status inHER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines. JAMA Oncology. 5(3). 366–366. 25 indexed citations
5.
Press, Michael F., Ivonne Villalobos, Angela Santiago, et al.. (2016). Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice. Archives of Pathology & Laboratory Medicine. 140(11). 1250–1258. 50 indexed citations
6.
Press, Oliver W., et al.. (2014). Characterization of HER2 Status by Fluorescence In Situ Hybridization (FISH) and Immunohistochemistry (IHC). Methods in molecular biology. 1180. 181–207. 4 indexed citations
7.
Press, Michael F., Tobias Grob, Andreas H. Marx, et al.. (2014). Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas.. Journal of Clinical Oncology. 32(15_suppl). 4072–4072. 1 indexed citations
8.
Press, Michael F., Guido Sauter, Marc Buyse, et al.. (2010). Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy. Journal of Clinical Oncology. 29(7). 859–867. 146 indexed citations
9.
Livingston, Robert B., María Koehler, Michael Arbushites, et al.. (2010). Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer. Clinical Cancer Research. 16(4). 1281–1288. 25 indexed citations
10.
Press, Michael F., Richard S. Finn, David Cameron, et al.. (2008). HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer. Clinical Cancer Research. 14(23). 7861–7870. 134 indexed citations
11.
Press, Michael F., Guido Sauter, Leslie Bernstein, et al.. (2005). Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials. Clinical Cancer Research. 11(18). 6598–6607. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026